Zimmer to float $7.7B debt to acquire Biomet
March 11, 2015 by Brad Perriello
Zimmer said it agreed to float some $7.65 billion in senior notes to help finance its $13.35 billion buyout of cross-town orthopedics rival Biomet.
Warsaw, Ind.-based Zimmer said it expects the notes offering to close March 19, with the merger slated to go on the books by the end of the 1st quarter “or shortly thereafter.” Read more
Becton Dickinson's $12B CareFusion buyout set to close tomorrow
March 16, 2015 by Brad Perriello
The $12.2 billion merger of Becton Dickinson and CareFusion is slated to close tomorrow, the companies said, after European anti-trust regulators last week approved the deal.
Franklin Lakes, N.J.-based Becton agreed last October to pay a total of $58.00 a share – $49.00 in cash and 0.0777 of a BDX share – for each CFN share, representing a premium of 26% to the closing price on Oct. 3. Read more
Private equity shops battle for Philips' legacy lighting biz
March 12, 2015 by MassDevice
A consortium of private equity firms CVC Capital Partners and Kohlberg Kravis Roberts put up the highest bid to take control of Royal Philips’ legacy lighting business, though rival Bain Capital could still make a better offer, 3 sources familiar with the matter said.
Philips is keen to keep the bid battle going until the end of the week in an effort to get the best price for the asset which could be valued at roughly €2.5 billion ($2.6 billion), the sources said. Read more
Digirad acquires mobile-imaging group MD Office Solutions
March 16, 2015 by Val Kennedy
Georgia-based Digirad Corp. has expanded its geographical reach by acquiring MD Office Solutions, a mobile-diagnostic services provider focused on the Northern California market.
Under the terms of the deal, Digirad paid 610,000 common shares up front. MD Office Solutions investors could also receive up to $400,000 over 3 years if certain EBITDA targets are met. Read more
Becton Dickinson closes $12B CareFusion buyout
March 17, 2015 by Brad Perriello
Becton Dickinson closed its $12.2 billion merger with CareFusion, as expected after European anti-trust regulators last week approved the deal.
Franklin Lakes, N.J.-based Becton agreed last October to pay a total of $58.00 a share – $49.00 in cash and 0.0777 of a BDX share – for each CFN share, representing a premium of 26% to the closing price on Oct. 3. Read more
The post ZMH to float $7.7B debt to acquire Biomet | The week in medtech M&A appeared first on MassDevice.